| N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4-(morpholinomethyl)-[1,1-biphenyl]-3-carboxamide | |
| Other names： | EPZ-6438; Tazemetostat |
| Cas No： | 1403254-99-8 |
| Molecular formula： | C34H44N4O4 |
| Molecular weight： | 57274 |
| Purity： | 98% |
| N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4-(morpholinomethyl)-[1,1-biphenyl]-3-carboxamide | |
| Other names： | EPZ-6438; Tazemetostat |
| Cas No： | 1403254-99-8 |
| Molecular formula： | C34H44N4O4 |
| Molecular weight： | 57274 |
| Purity： | 98% |
| N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4-(morpholinomethyl)-[1,1-biphenyl]-3-carboxamide | |
| Other names： | EPZ-6438; Tazemetostat |
| Cas No： | 1403254-99-8 |
| Molecular formula： | C34H44N4O4 |
| Molecular weight： | 57274 |
| Purity： | 98% |